🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Evaluating

Evaluating the Impact of Vitamin D Supplementation on Healing Bed Sores in ICU. NCT07813975NA1 site📍 Cairo Maha Salah · Tests: Enteral Vit-D 3 (cholecalciferol) Beneficial Effect of Silymarin in Ulcerative Colitis NCT06213857Phase 22 sites📍 Asyut📍 Asyut Tanta University · Tests: Silymarin, Mesalamine, Azathioprine An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors NCT07222267Phase 132 sites📍 Birmingham📍 New Haven📍 St Louis BeOne Medicines · Tests: BG-75202, CDK4 Inhibitor, Estrogen Receptor Antagonist, Aromatase Inhibitor Suitability of a 26 °C Indoor Environment for Mitigating Heat Strain in Young Adults NCT07267598NA1 site📍 Ottawa University of Ottawa · Tests: Simulated indoor temperature upper limit Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas NCT07014163NA2 sites📍 Tehran📍 Tehran Espad Pharmed · Tests: Embella (Deoxycholic acid, produced by Espad Pharmed Co.) MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors NCT06912152Phase 11 site📍 Hangzhou Zhejiang University · Tests: MT027 CAR-T cells Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant NCT06657248n/a4 sites📍 Bünde📍 Brakel📍 München Aesculap AG · Tests: univation® XF Pro ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) NCT06415487Phase 19 sites📍 San Diego📍 Denver📍 Nashville Acepodia Biotech, Inc. · Tests: Cyclophosphamide, Fludarabine, ACE2016, Pembrolizumab Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites📍 Los Angeles📍 New Haven📍 New Haven Pfizer · Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors NCT06936735Phase 11 site📍 Shanghai Hansoh BioMedical R&D Company · Tests: HS-20108 Monotherapy Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer. NCT05378204NA25 sites📍 Bordeaux📍 Caen📍 Clermont-Ferrand Institut Claudius Regaud · Tests: Main study:, Sub-study: A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) NCT07373964Phase 21 site📍 Shenyang China Medical University, China · Tests: Chidamide Tablets； PD-L1 Inhibitor (as per chosen drug's prescribing information)；Carboplatin； Etoposide GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer NCT07489287Phase 11 site📍 Buffalo Roswell Park Cancer Institute · Tests: GB-5267 - IV only, GB-5267 -Combined IV and IP Infusion Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy NCT07789184Phase 331 sites📍 Beijing📍 Beijing📍 Beijing Hua Huang, MD, PhD · Tests: Radical Gastrectomy with D2 Lymphadenectomy, Standard Systemic Therapy for Advanced Gastric Cancer A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors NCT06716138Phase 15 sites📍 New York📍 Fuzhou📍 Guangzhou Avistone Biotechnology Co., Ltd. · Tests: ANS03 Study of Tadalafil vs. Placebo for Improving Hemodynamics and End-Organ Dysfunction in Fontan Physiology NCT05206955Phase 31 site📍 Rochester Mayo Clinic · Tests: Tadalafil, Placebo GynMDD Add-On to Supportive Psychotherapy in Mild to Moderate Depression NCT07416747NA1 site📍 Créteil Fondation FondaMental · Tests: GynMDD, Placebo Long-term COVID and Rehabilitation NCT05373043NA1 site📍 Salt Lake City VA Office of Research and Development · Tests: Mitoquinone, Placebo Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer NCT05574647NA15 sites📍 Southend-on-Sea📍 Southampton📍 Gillingham Imperial College London · Tests: bpMRI, Image-Fusion targeted and systematic Biopsy Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus NCT07237685n/a2 sites📍 Amsterdam📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS) NCT06738758n/a1 site📍 Beijing Yun Dai Chen · Tests: PCSK9 inhibitor, Statin+Ezetimibe/Hybutimibe compound, Statin PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer NCT07426055Phase 2, Phase 31 site📍 Zamość Affidea Nu-med Center of Oncological DIagnostics and Therapy · Tests: Stereotactic Body Radiotherapy (SBRT) Monotherapy, External Beam Radiotherapy (EBRT) Backbone, High-Dose-Rate Brachythe… Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer NCT07189455Phase 31 site📍 Shanghai Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Tests: ZG006, Topotecan Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1% NCT06645821EARLY Phase 11 site📍 Norfolk Virginia Clinical Research, Inc. · Tests: EVO101 Hemodynamic Impact of the Administration of PAracetamol in Patients Hospitalized in the Intensive Resuscitation Medicine Department [PAREA] NCT06430697NA1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: paracetamol administration Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy. NCT06766058NA1 site📍 Singapore National Cancer Centre, Singapore · Tests: Carrier oil, Asian plant extract blend A National Swedish Study Evaluating Dd-cfDNA for as a Diagnostic Biomarker for Rejection Surveillence in Heart Transplantation NCT07531784n/a1 site📍 Stockholm Karolinska Institutet · Tests: dd-cfDNA Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery NCT06970925EARLY Phase 11 site📍 Englewood Englewood Hospital and Medical Center · Tests: Sucrosomial Iron (SI) Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119 NCT06504290Phase 14 sites📍 Beijing📍 Beijing📍 Beijing Vigonvita Life Sciences · Tests: VV119 Placebo （in healthy adult subjects）, VV119 （in healthy adult subjects）, VV119(in adult patients with schizophreni… A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies NCT06994806Phase 115 sites📍 Phoenix📍 Los Angeles📍 Denver Kumquat Biosciences Inc. · Tests: KQB168, Pembrolizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy